Skip to main contentSkip to page footer

Funding and Collaborations

Funding

  • Deutsche Forschungsgemeinschaft, GRK2504.1-2, Research Training Group–401821119 (Teilprojekt A1): „CDK7 kinase pathways as a drug targeting strategy for broad antiherpesviral intervention“
  • Deutsche Forschungsgemeinschaft (MA1289/11-3, MA1289/17-1; Profs. M. Marschall, H. Sticht, J. Eichler)
  • Bayerische Forschungsstiftung (Coordination of consortial joint projects DeeP-CMV and IMU-COVID; eight or two consortial partners each)
  • Volkswagenstiftung (Az9B783; Profs. S.B. Tsogoeva, M. Marschall)
  • Wilhelm Sander-Stiftung (2018.121.1, Profs. H. Sticht, M. Marschall)
  • Forschungsstiftung Medizin UKER, together with Manfred Roth-Stiftung Fürth (Prof. M. Marschall and members of the research group)
  • DAAD-Go8, German-Australian Joint Research Program (Profs. W.D. Rawlinson, M. Marschall)

Collaborations

  • Prof. Dr. Siwaporn Boonyasuppayakorn, Division of Virology, Chulalongkorn University, Bangkok, Thailand
  • Dr. Eva Maria Borst, Department of Virology, Hannover Medical School, Hannover, Germany
  • Dr. Yohann Couté, Laboratoire Biologie à Grande Echelle (BGE), Exploring the Dynamics of Proteomes (EDyP), INSERM/CEA/Université Grenoble, France
  • Prof. Dr. Jutta Eichler, Department of Chemistry and Pharmacy, FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Tanatorn Khotavivattana, Department of Chemistry, Chulalongkorn University, Bangkok, Thailand
  • Dr. Jan Eickhoff, Dr. Bert Klebl, Lead Discovery Center GmbH, Dortmund
  • Dr. Thomas Hoffmann, Tahrget Therapeutics Ltd., Limassol, Cyprus
  • Prof. Dr. Benedikt Kaufer, Institute of Virology, Free University of Berlin, Germany
  • Dr. Hella Kohlhof, Dr. Christian Gege, Dr. Alexandra Herrmann, Dr. Daniel Vitt, Immunic AG, Gräfelfing/München, Germany
  • Prof. Thierry Langer, Dr. Verena Battisti, Pharmaceutical Chemistry, University of Vienna, Austria
  • Dr. Tihana Lenac, Prof. Dr. Stipan Jonjic, Department of Histology and Embryology, University of Rijeka, Croatia
  • Dr. Peter Lischka, AiCuris Anti-infective Cures GmbH, Wuppertal, Germany
  • Prof. Dr. Yves Muller, Division of Biotechnology, Department of Biology, FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Bodo Plachter, Institute for Virology, University of Mainz, Germany
  • Prof. Dr. William D. Rawlinson, Dr. Stuart Hamilton, Virology Division, Microbiology Department, University NSW, Prince of Wales Hospital, Sydney, Australia
  • Dr. Eileen Socher, Institute of Anatomy, Functional and Clinical Anatomy, FAU, Erlangen-Nürnberg, Germany
  • Prof. Dr. Thomas Stamminger, Institute for Virology, University of Ulm, Germany
  • Prof. Dr. Heinrich Sticht, Division of Bioinformatics, Institute of Biochemistry, FAU Erlangen-Nürnberg, Germany
  • Prof. Dr. Svetlana Tsogoeva, Institute of Organic Chemistry, FAU Erlangen-Nürnberg, Germany
  • Dr. DongHoon Yu, Dr. Kiyean Nam, Qurient Inc., Seongnam-si, Korea